資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/27708
|
| 標題: | Docosahexaenoic Acid Promotes Dopaminergic Differentiation in Induced Pluripotent Stem Cells and Inhibits Teratoma Formation in Rats With Parkinson-Like Pathology |
| 作者: | Chang, Yuh-Lih
Chen, Shih-Jen
Kao, Chung-Lan
Hung, Shih-Chieh
Ding, Dah-Ching
Yu, Cheng-Chia
Chen, Yi-Jen
Ku, Hung-Hai
Lin, Chin-Po
Lee, Kun-Hsiung
Chen, Yu-Chih
Wang, Jhi-Joung
Hsu, Chuan-Chih
Chen, Liang-Kung
Li, Hsin-Yang
Chiou, Shih-Hwa |
| 貢獻者: | 藥學系
休閒保健管理系 |
| 關鍵字: | Parkinson'S Disease
Dopamine
Induced Pluripotent Stem Cells (Ips)
Dopaminergic Neurons
Docosahexaenoic Acid (Dha)
3T-Mri |
| 日期: | 2012-01 |
| 上傳時間: | 2014-03-21 16:18:21 (UTC+8) |
| 出版者: | Cognizant Communication Corp |
| 摘要: | Parkinson's disease (PD) is a neurodegenerative disorder characterized by the degeneration of dopaminergic (DA) neurons in the midbrain. Induced pluripotent stem (iPS) cells have shown potential for differentiation and may become a resource of functional neurons for the treatment of PD. However, teratoma formation is a major concern for transplantation-based therapies. This study examined whether functional neurons could be efficiently generated from iPS cells using a five-step induction procedure combined with docosahexaenoic acid (DHA) treatment. We demonstrated that DHA, a ligand for the RXR/Nurr1 heterodimer, significantly activated expression of the Nurr1 gene and the Nurr1-related pathway in iPS cells. DHA treatment facilitated iPS differentiation into tyrosine hydroxylase (TH)-positive neurons in vitro and in vivo and functionally increased dopamine release in transplanted grafts in PD-like animals. Furthermore, DHA dramatically upregulated the endogenous expression levels of neuroprotective genes (Bcl-2, Bcl-xl, brain-derived neurotrophic factor, and glial cell-derived neurotrophic factor) and protected against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced apoptosis in iPS-derived neuronal precursor cells. DHA-treated iPS cells significantly improved the behavior of 6-hydroxydopamine (6-OHDA)-treated PD-like rats compared to control or eicosapentaenoic acid-treated group. Importantly, the in vivo experiment suggests that DHA induces the differentiation of functional dopaminergic precursors and improves the abnormal behavior of 6-OHDA-treated PD-like rats by 4 months after transplantation. Furthermore, we found that DHA treatment in iPS cell-grafted rats significantly downregulated the mRNA expression of embryonic stem cell-specific genes (Oct-4 and c-Myc) in the graft and effectively blocked teratoma formation. Importantly, 3 Tesla-magnetic resonance imaging and ex vivo green fluorescence protein imaging revealed that no teratomas were present in transplanted grafts of DHA-treated iPS-derived DA neurons 4 months after implantation. Therefore, our data suggest that DHA plays a crucial role in iPS differentiation into functional DA neurons and that this approach could provide a novel therapeutic approach for PD treatment. |
| 關聯: | Cell Transplantation, v.21 n.1 pp.313-332(20) |
| 顯示於類別: | [藥學系(所)] 期刊論文
[休閒保健管理系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 2178 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
